Abbott Laboratories/ US0028241000 /
| 2024-04-25 9:59:57 PM | Chg. -0.04 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 106.86USD | -0.04% | 57,732 Turnover: 6.16 mill. |
-Bid Size: - | -Ask Size: - | 185.42 bill.USD | 1.95% | 32.58 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.28 USD | -16.75% |
| EPS Diluted: | 3.26 USD | -16.62% |
| Revenues per Share: | 23.12 USD | -7.97% |
| Book Value per Share: | 22.38 USD | 5.38% |
| Cash Flow per Share: | 4.18 USD | -24.09% |
| Dividend per Share: | 2.08 USD | 8.33% |
| Total | in mill. | |
| Revenues: | 40,109.00 USD | -8.12% |
| Net Income: | 5,723.00 USD | -17.45% |
| Operating Cash Flow: | 7,261.00 USD | - |
| Cash and Cash Equivalents: | 6,896.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 32.58 | 33.56 |
| P/S Ratio: | 4.62 | 4.76 |
| P/BV ratio: | 4.78 | 4.92 |
| P/CF Ratio: | 25.54 | 26.30 |
| PEG: | -1.94 | -2.00 |
| Earnings Yield: | 3.07% | 2.98% |
| Dividend Yield: | 1.95% | 1.89% |
| Market Capitalization | ||
| Market Capitalization: | 185.42 bill. USD | 190.99 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 1.74 bill. | |
Profitability
| Gross Profit Margin: | 55.18% |
| EBIT Margin: | 16.15% |
| Net Profit Margin: | 14.27% |
| Return on Equity: | 14.74% |
| Return on Assets: | 7.82% |
Financial Strength
| Liquidity I / Cash Ratio: | 49.82% |
| Liquidity II / Quick Ratio: | 97.25% |
| Liquidity III / Current Ratio: | 163.79% |
| Debt / Equity Ratio: | 88.56% |
| Dynam. Debt / Equity Ratio: | 473.58% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
